Takashi Toyama Selected Research

Takashi Toyama Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 06/2003
4	Heart Failure 11/2018 - 02/2005
4	Neuroblastoma 12/2015 - 01/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2014
2	Inflammation (Inflammations) 01/2021 - 01/2020
2	Chronic Hepatitis C 07/2006 - 07/2004
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Weight Loss (Weight Reduction) 01/2019
1	Infarction (Infarctions) 11/2018
1	Hypoxia (Hypoxemia) 11/2018
1	Fibrosis (Cirrhosis) 01/2017
1	Hyperglycemia 01/2017
1	Anemia 10/2014
1	Parkinsonian Disorders (Parkinsonism) 09/2014
1	Parkinson Disease (Parkinson's Disease) 09/2014
1	Myocardial Infarction 01/2014
1	Chronic Hepatitis B 12/2012
1	Splenic Rupture 02/2012
1	Splenomegaly 02/2012
1	Lymphoid Leukemia 02/2012
1	Familial duodenal atresia 11/2011
1	Rectal Neoplasms (Rectal Cancer) 11/2011
1	Gallbladder Neoplasms (Gallbladder Cancer) 11/2011
1	Carcinoma (Carcinomatosis) 08/2010
1	Ileus 08/2010
1	Liver Diseases (Liver Disease) 07/2006
1	Hypoalbuminemia 05/2005
1	Acute Liver Failure (Fulminant Hepatic Failure) 05/2005
1	Hepatocellular Carcinoma (Hepatoma) 06/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2017
3	Ribavirin (Virazole)FDA LinkGeneric 10/2014 - 07/2004
3	InterferonsIBA 10/2014 - 07/2004
2	FilaminsIBA 01/2019 - 11/2018
2	Cysteine (L-Cysteine)FDA Link 08/2014 - 01/2014
2	Sulfhydryl Compounds (Thiols)IBA 08/2014 - 01/2014
2	Gemcitabine FDA Link 11/2011 - 08/2010
1	Gefitinib (Iressa)FDA Link 01/2021
1	EnzymesIBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Pyruvate KinaseIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	PutrescineIBA 09/2020
1	elaidic acidIBA 01/2020
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2020
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	cilnidipineIBA 11/2018
1	NADPH Oxidase 2IBA 01/2017
1	TRPC6 Cation ChannelIBA 01/2017
1	TRPC3 cation channelIBA 01/2017
1	HydrolasesIBA 12/2015
1	UbiquitinIBA 12/2015
1	Erythropoietin FDA Link 10/2014
1	telaprevirIBA 10/2014
1	CreatinineIBA 10/2014
1	catechol (pyrocatechol)IBA 09/2014
1	1- (3',4'- dihydroxybenzyl)- 1,2,3,4- tetrahydroisoquinolineIBA 09/2014
1	Dopamine (Intropin)FDA LinkGeneric 09/2014
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 09/2014
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 09/2014
1	Buthionine SulfoximineIBA 05/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2014
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014
1	SulfurIBA 01/2014
1	Lamivudine (Epivir)FDA Link 12/2012
1	lipoarabinomannan (LAM)IBA 12/2012
1	adefovir dipivoxil (Hepsera)FDA Link 12/2012
1	sodium bisulfide (NaHS)IBA 10/2011
1	Small Interfering RNA (siRNA)IBA 10/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	Cisplatin (Platino)FDA LinkGeneric 08/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2010
1	Etoposide (VP 16)FDA LinkGeneric 08/2010
1	Messenger RNA (mRNA)IBA 02/2010
1	Pyrazinamide FDA LinkGeneric 05/2005
1	SB 203580IBA 06/2003
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2003
1	p38 Mitogen-Activated Protein KinasesIBA 06/2003

Therapy/Procedure

4	Therapeutics 10/2014 - 07/2004
3	Drug Therapy (Chemotherapy) 02/2012 - 08/2010
1	Drug Tapering 10/2014
1	Splenectomy 02/2012
1	Arterial Switch Operation 02/2005